Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trials
Depressive symptoms after first XR-naltrexone injection are associated with nonreceipt of a second injection. Clinicians should educate patients about this risk and monitor for possible depression symptoms after the first injection.
Authors
- Maria A. Sullivan (ORCID: https://orcid.org/0000-0003-1940-9060)
- Miranda Greiner (ORCID: https://orcid.org/0000-0003-3768-527X)
- Adam Bisaga (ORCID: https://orcid.org/0000-0003-4243-6462)
- Matisyahu Shulman (ORCID: https://orcid.org/0000-0002-2941-8895)
- Edward V. Nunes (ORCID: https://orcid.org/0000-0002-2055-3425)
- Onumara Opara
- Kaitlyn Ohrtman
- Mei‐Chen Hu (ORCID: https://orcid.org/0000-0001-7333-0527)
Institutions
- Alkermes (United States) (US)
- Columbia University (US)
Publication Details
- Journal
- American Journal on Addictions
- Published
- 2025-06-08
- DOI
- https://doi.org/10.1111/ajad.70055
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00